EP3139935A4 - Compositions placentaires thérapeutiques, procédés de fabrication et méthodes d'utilisation - Google Patents

Compositions placentaires thérapeutiques, procédés de fabrication et méthodes d'utilisation Download PDF

Info

Publication number
EP3139935A4
EP3139935A4 EP14891336.1A EP14891336A EP3139935A4 EP 3139935 A4 EP3139935 A4 EP 3139935A4 EP 14891336 A EP14891336 A EP 14891336A EP 3139935 A4 EP3139935 A4 EP 3139935A4
Authority
EP
European Patent Office
Prior art keywords
methods
making
placental compositions
therapeutic placental
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP14891336.1A
Other languages
German (de)
English (en)
Other versions
EP3139935A1 (fr
Inventor
Timothy Jansen
Samson Tom
Alla Danilkovitch
Dana Yoo
Jaime Zerhusen
Gabriele Putz TODD
Amy Elizabeth Johnson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Osiris Therapeutics Inc
Original Assignee
Osiris Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osiris Therapeutics Inc filed Critical Osiris Therapeutics Inc
Publication of EP3139935A1 publication Critical patent/EP3139935A1/fr
Publication of EP3139935A4 publication Critical patent/EP3139935A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pregnancy & Childbirth (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP14891336.1A 2014-05-07 2014-05-07 Compositions placentaires thérapeutiques, procédés de fabrication et méthodes d'utilisation Withdrawn EP3139935A4 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2014/037201 WO2015171142A1 (fr) 2014-05-07 2014-05-07 Compositions placentaires thérapeutiques, procédés de fabrication et méthodes d'utilisation

Publications (2)

Publication Number Publication Date
EP3139935A1 EP3139935A1 (fr) 2017-03-15
EP3139935A4 true EP3139935A4 (fr) 2017-11-15

Family

ID=54392804

Family Applications (1)

Application Number Title Priority Date Filing Date
EP14891336.1A Withdrawn EP3139935A4 (fr) 2014-05-07 2014-05-07 Compositions placentaires thérapeutiques, procédés de fabrication et méthodes d'utilisation

Country Status (7)

Country Link
EP (1) EP3139935A4 (fr)
JP (1) JP2017514876A (fr)
KR (1) KR20160147058A (fr)
AU (1) AU2014393402A1 (fr)
CA (1) CA2948126A1 (fr)
SG (1) SG11201609254YA (fr)
WO (1) WO2015171142A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3351625A1 (fr) 2010-02-18 2018-07-25 Osiris Therapeutics, Inc. Procédés de fabrication de produits de membrane chorionique immunocompatible
JP7011135B2 (ja) * 2016-02-19 2022-02-10 佳秀工業株式会社 血管内皮増殖因子産生促進剤の製造方法及び発毛剤の製造方法、並びに血管内皮増殖因子産生促進剤及び発毛剤
CN109069867B (zh) * 2016-03-14 2022-02-01 无痛疗法股份有限公司 无细胞胎盘制剂
WO2017165698A1 (fr) 2016-03-23 2017-09-28 Mimedx Group, Inc. Compositions et méthodes de traitement faisant appel au liquide amniotique
AU2017316682B2 (en) 2016-08-24 2020-10-15 Arthrex, Inc. Tissue use for repair of injury
WO2018144694A1 (fr) 2017-02-01 2018-08-09 Plakous Therapeutics, Inc. Compositions de tissu placentaire
US11511017B2 (en) 2019-03-12 2022-11-29 Arthrex, Inc. Ligament reconstruction
WO2021003257A1 (fr) * 2019-07-01 2021-01-07 Auxocell Laboratories, Inc. Procédés et compositions pour collecter et utiliser des cellules de tissu placentaire et des cellules sanguines placentaires
WO2021101802A2 (fr) * 2019-11-21 2021-05-27 Bioventus, Llc . Compositions particulaires de tissu placentaire et méthodes d'utilisation
WO2021123320A1 (fr) * 2019-12-20 2021-06-24 Dr. Kalali Prof. Mostafazadeh Dipl. Ing. Miedl (Kmm) Gesellschaft Bürgerlichen Rechts Composition et son utilisation pour une thérapie universelle contre les cellules tumorales
KR102116954B1 (ko) * 2019-12-26 2020-05-29 주식회사 엠케이바이오텍 태아 유래 줄기세포의 동결 보존 및 동결 건조용 배지 조성물
WO2021211961A1 (fr) * 2020-04-17 2021-10-21 Crown Scientific, L.L.C. Compositions anti-inflammatoires non stéroïdiennes régénérantes, leurs procédés de production et leurs procédés d'utilisation
US12453805B2 (en) 2020-09-24 2025-10-28 Everest Medical Innovation GmbH Cryoprotective compositions, surgical kits, and methods for protection of a surgical site during cryosurgery
US12426594B2 (en) 2020-09-24 2025-09-30 Everest Medical Innovation GmbH Cryoprotective compositions and methods for protection of a surgical site during cryosurgery
WO2022074523A1 (fr) * 2020-10-06 2022-04-14 Osiris Therapeutics, Inc. Tissu placentaire amorcé et utilisations en médecine régénérative
JP2024509124A (ja) * 2021-02-26 2024-02-29 アルグラ サイエンシズ エルエルシー 絨毛間質細胞組成物及びその使用
WO2023192484A2 (fr) * 2022-04-01 2023-10-05 Bright Cell, Inc. Formulation de cellules souches mésenchymateuses à usage cosmétique
US20240226181A1 (en) * 2023-01-11 2024-07-11 Biostem Technologies, Inc. Human umbilical cord composition for treatment of peyronie's disease

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009120996A1 (fr) * 2008-03-27 2009-10-01 Biolife Solutions, Inc. Procédé, système et appareil pour la collecte, le stockage, le transport et le placement en banque de sang de tissu natal
EP2702871A1 (fr) * 2002-03-26 2014-03-05 Anthrogenesis Corporation Texture biologique collagène et procédés de préparation et d'utilisation associés
US20140106447A1 (en) * 2012-10-12 2014-04-17 Mimedx Group, Inc. Compositions and methods for recruiting stem cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7331350B2 (en) * 2000-02-11 2008-02-19 The General Hospital Corporation Photochemical tissue bonding
EP2399990B1 (fr) * 2003-06-27 2015-07-22 DePuy Synthes Products, Inc. Cellules dérivées de cordon ombilical post-partum pour l'utilisation dans le traitement de maladies du coeur et du système circulatoire
EP3351625A1 (fr) * 2010-02-18 2018-07-25 Osiris Therapeutics, Inc. Procédés de fabrication de produits de membrane chorionique immunocompatible
US8632512B2 (en) * 2010-04-09 2014-01-21 Kci Licensing, Inc. Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2702871A1 (fr) * 2002-03-26 2014-03-05 Anthrogenesis Corporation Texture biologique collagène et procédés de préparation et d'utilisation associés
WO2009120996A1 (fr) * 2008-03-27 2009-10-01 Biolife Solutions, Inc. Procédé, système et appareil pour la collecte, le stockage, le transport et le placement en banque de sang de tissu natal
US20140106447A1 (en) * 2012-10-12 2014-04-17 Mimedx Group, Inc. Compositions and methods for recruiting stem cells

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JI SUK CHOI ET AL: "Full-Thickness Skin Wound Healing Using Human Placenta-Derived Extracellular Matrix Containing Bioactive Molecules", TISSUE ENGINEERING PART A, vol. 19, no. 3-4, 1 February 2013 (2013-02-01), pages 329 - 339, XP055395217, ISSN: 1937-3341, DOI: 10.1089/ten.tea.2011.0738 *

Also Published As

Publication number Publication date
CA2948126A1 (fr) 2015-11-12
EP3139935A1 (fr) 2017-03-15
AU2014393402A1 (en) 2016-11-24
KR20160147058A (ko) 2016-12-21
JP2017514876A (ja) 2017-06-08
WO2015171142A1 (fr) 2015-11-12
SG11201609254YA (en) 2016-12-29

Similar Documents

Publication Publication Date Title
CA3244408A1 (en) Therapeutic compositions, combinations, and methods of use
EP3139935A4 (fr) Compositions placentaires thérapeutiques, procédés de fabrication et méthodes d'utilisation
EP3242672A4 (fr) Composition thérapeutique dérivée d'amnios et son procédé de production
EP3245291A4 (fr) Nouvelles micro-dystrophines et méthodes d'utilisation associées
EP3199628A4 (fr) Agent thérapeutique induisant une cytotoxicité
EP3160470A4 (fr) Analogues de pridopidine, leur préparation et utilisation
EP3167046A4 (fr) Production et cryopréservation de cellules fucosylées à usage thérapeutique
EP3204386A4 (fr) Composés aminopurine substitués, compositions correspondantes, et procédés de traitement les utilisant
EP3104948A4 (fr) Jouet de stimulation sensorielle, interactif parent-bébé, et procédés d'utilisation
EP3102200A4 (fr) Composés et compositions thérapeutiques
EP3116898A4 (fr) Utilisation de la protéine m013 exprimée par un vecteur aav comme agent thérapeutique anti-inflammatoire
EP3194564A4 (fr) Compositions de trichoderma et procédés d'utilisation
EP3094606A4 (fr) Compositions de ciment, structures et procédés d'utilisation
EP3224362A4 (fr) Compositions thérapeutiques comprenant des facteurs de transcription et leurs procédés de préparation et d'utilisation
EP3166892A4 (fr) Compositions anti-calcaire et procédés de fabrication et d'utilisation associés
EP3265096A4 (fr) Compositions ophtalmiques et leurs procédés d'utilisation
EP3139928A4 (fr) Compositions d'anordrine et méthodes de traitement de maladies
EP3125963A4 (fr) Compositions de remplissage de tissus et méthodes d'utilisation
EP3110446A4 (fr) Procédés et compositions pour le traitement de maladies associées à siglec-8
EP3190886A4 (fr) Compositions et méthodes d'utilisation de ces compositions
EP3136879A4 (fr) Compositions de protéines concentrées et procédés pour les préparer et les utiliser
EP3117827A4 (fr) Composition vaginale et son utilisation
EP3247365A4 (fr) Nouvelle composition iodophore et procédés d'utilisation
EP3131556A4 (fr) Méthodes et compositions pour le traitement de maladies liées à la bpco
EP3183243A4 (fr) Composés d'organotellure, leurs compositions et méthodes d'utilisation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20161118

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20171013

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 35/50 20150101AFI20171009BHEP

Ipc: A61P 17/02 20060101ALI20171009BHEP

17Q First examination report despatched

Effective date: 20180702

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20181113